162 related articles for article (PubMed ID: 12633128)
1. Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients.
Sharpley AL; Bhagwagar Z; Hafizi S; Whale WR; Gijsman HJ; Cowen PJ
J Clin Psychiatry; 2003 Feb; 64(2):192-6. PubMed ID: 12633128
[TBL] [Abstract][Full Text] [Related]
2. Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers.
Giménez S; Clos S; Romero S; Grasa E; Morte A; Barbanoj MJ
Psychopharmacology (Berl); 2007 Mar; 190(4):507-16. PubMed ID: 17205319
[TBL] [Abstract][Full Text] [Related]
3. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
4. Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86.
Riemann D; Hohagen F; Bahro M; Berger M
Eur Arch Psychiatry Clin Neurosci; 1994; 243(5):279-90. PubMed ID: 8172943
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder.
Barbee JG; Conrad EJ; Jamhour NJ
J Clin Psychiatry; 2004 Jul; 65(7):975-81. PubMed ID: 15291687
[TBL] [Abstract][Full Text] [Related]
6. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression.
Keitner GI; Garlow SJ; Ryan CE; Ninan PT; Solomon DA; Nemeroff CB; Keller MB
J Psychiatr Res; 2009 Jan; 43(3):205-14. PubMed ID: 18586273
[TBL] [Abstract][Full Text] [Related]
8. Effect of bupropion-SR on REM sleep: relationship to antidepressant response.
Ott GE; Rao U; Nuccio I; Lin KM; Poland RE
Psychopharmacology (Berl); 2002 Dec; 165(1):29-36. PubMed ID: 12474115
[TBL] [Abstract][Full Text] [Related]
9. Sertraline and rapid eye movement sleep without atonia: an 8-week, open-label study of depressed patients.
Zhang B; Hao Y; Jia F; Tang Y; Li X; Liu W; Arnulf I
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():85-92. PubMed ID: 23994660
[TBL] [Abstract][Full Text] [Related]
10. Heart rate variability and cordance in rapid eye movement sleep as biomarkers of depression and treatment response.
Pawlowski MA; Gazea M; Wollweber B; Dresler M; Holsboer F; Keck ME; Steiger A; Adamczyk M; Mikoteit T
J Psychiatr Res; 2017 Sep; 92():64-73. PubMed ID: 28411417
[TBL] [Abstract][Full Text] [Related]
11. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
[TBL] [Abstract][Full Text] [Related]
12. Effects of fluoxetine on the polysomnogram in outpatients with major depression.
Trivedi MH; Rush AJ; Armitage R; Gullion CM; Grannemann BD; Orsulak PJ; Roffwarg HP
Neuropsychopharmacology; 1999 May; 20(5):447-59. PubMed ID: 10192825
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.
Sharpley AL; Attenburrow ME; Hafizi S; Cowen PJ
J Clin Psychiatry; 2005 Apr; 66(4):450-4. PubMed ID: 15816787
[TBL] [Abstract][Full Text] [Related]
14. Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
Jacobsen FM
J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159
[TBL] [Abstract][Full Text] [Related]
15. Risperidone in the treatment of schizotypal personality disorder.
Koenigsberg HW; Reynolds D; Goodman M; New AS; Mitropoulou V; Trestman RL; Silverman J; Siever LJ
J Clin Psychiatry; 2003 Jun; 64(6):628-34. PubMed ID: 12823075
[TBL] [Abstract][Full Text] [Related]
16. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
17. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
Bai YM; Yu SC; Lin CC
J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
Wolf R; Dykierek P; Gattaz WF; Maras A; Kohnen R; Dittmann RW; Geuppert M; Riemann D; Berger M
Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
[TBL] [Abstract][Full Text] [Related]
19. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic phenelzine treatment on REM sleep: report of three patients.
Landolt HP; de Boer LP
Neuropsychopharmacology; 2001 Nov; 25(5 Suppl):S63-7. PubMed ID: 11682276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
